Precision Medicine in Peritoneal Dialysis: An Expert Opinion on the Application of the Sharesource Platform for the Remote Management of Patients.
automated peritoneal dialysis
cloud-based platform
remote monitoring
telemedicine
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
30 Jul 2024
30 Jul 2024
Historique:
received:
14
06
2024
revised:
12
07
2024
accepted:
24
07
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
epublish
Résumé
The management of end-stage kidney disease (ESKD) has been constantly evolving over the last decade with the development of targeted approaches. In this field, telemedicine and remote monitoring are based on the availability of new cyclers that allow for bidirectional communication (between patient and physician) and for the application of the Sharesource cloud-based platform. These technologies allow patients with ESKD to undergo automated peritoneal dialysis (APD) at home. However, these approaches are not well standardized and largely applied yet. Therefore, this study aimed to elaborate a protocol for the utilization of the Sharesource platform to facilitate the practical management of patients treated with APD. A series of expert meetings were held between September 2022 and January 2023 in Italy. The participants (ten nephrologists and five nurses) from nine Italian public dialysis centers shared their opinions, examined the current scientific literature in the field, and reviewed the key characteristics of the Sharesource system to achieve a common position on this topic. A detailed and practical document containing experts' opinions and suggestions on the use of the Sharesource platform for the management of patients treated with APD was produced. This expert opinion might represent a new useful instrument in clinical practice for managing patients undergoing home-based peritoneal dialysis (PD) through the Sharesource platform, which is valid not only for Italy. These recommendations pave the way to novel patient-centered and personalized therapeutic approaches for ESKD and highlight the advantages of telemedicine and remote monitoring in the management of patients with ESKD undergoing PD and its positive impact on their quality of life.
Identifiants
pubmed: 39201999
pii: jpm14080807
doi: 10.3390/jpm14080807
pmc: PMC11355414
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
G Ital Nefrol. 2023 Jun 29;40(3):
pubmed: 37427898
Contrib Nephrol. 2019;197:9-16
pubmed: 34569509
G Ital Nefrol. 2024 Feb 28;41(1):
pubmed: 38426673
Nephron. 2021;145(6):702-710
pubmed: 34515160
J Nephrol. 2020 Dec;33(6):1301-1308
pubmed: 32779144
Adv Perit Dial. 2001;17:72-4
pubmed: 11510301
Kidney Int Suppl. 2006 Nov;(103):S96-S103
pubmed: 17080119
Am J Nephrol. 2020;51(6):480-482
pubmed: 32344420
J Nephrol. 2020 Feb;33(1):177-182
pubmed: 31529294
Int Urol Nephrol. 2022 Oct;54(10):2673-2681
pubmed: 35362819
Perit Dial Int. 2018 Jan-Feb;38(1):76-78
pubmed: 29311200
Ther Apher Dial. 2021 Dec;25(6):970-978
pubmed: 33634948
Perit Dial Int. 2022 May;42(3):288-296
pubmed: 33380265
Contrib Nephrol. 2019;197:44-53
pubmed: 34569511
Telemed J E Health. 2018 Apr;24(4):315-323
pubmed: 29024613
G Ital Nefrol. 2022 Aug 29;39(4):
pubmed: 36073334
Perit Dial Int. 2019 Sep-Oct;39(5):472-478
pubmed: 31337698
Perit Dial Int. 2020 Jul;40(4):363-367
pubmed: 32597314
Perit Dial Int. 2020 May;40(3):244-253
pubmed: 32063219
Clin Kidney J. 2020 Jul 16;13(3):265-268
pubmed: 32699612